What Is Theranostics? A Breakthrough in Cancer Care with Dr. Brandon Mancini, MBA, FACRO
What if doctors could see exactly where cancer is located and then deliver treatment directly to those cancer cells with precision?
In this episode of Take Care, Melody Mulaik is joined by Dr. Brandon Mancini, Medical Director at BAMF Health, to discuss theranostics: an innovative and rapidly growing approach to cancer treatment that combines diagnostics and therapy into one personalized treatment strategy.
Dr. Mancini explains how theranostics works, why it’s creating so much excitement in the cancer world, and how it’s already helping patients with prostate cancer and neuroendocrine tumors live longer with a better quality of life.
They also discuss the role of PET scans, how radioactive therapies specifically target cancer cells, the patient treatment journey, access to care through telehealth, and why this approach may become a major pillar of cancer care in the future.
Whether you’re a patient, caregiver, healthcare professional, or simply curious about the future of medicine, this episode offers an easy-to-understand introduction to one of the most promising breakthroughs in cancer treatment today.
What You’ll Learn in This Episode:
- What theranostics means and how it works
- How PET scans help identify cancer targets
- Why Theranostics is changing prostate cancer treatment
- The difference between theranostics and chemotherapy
- Who may qualify for theranostic therapies
- What patients can expect during treatment
- How telehealth is improving access to cancer specialists
- The future of personalized cancer care and clinical trials
Timestamps:
- [00:02:00] What theranostics is and how it combines therapy and diagnostics
- [00:04:00] Who qualifies for theranostic treatment for prostate cancer
- [00:07:00] Inside BAMF Health and the future of theranostics centers
- [00:13:00] What patients experience during treatment and recovery
- [00:23:00] Why theranostics may become a major pillar in cancer care
About the Guest:
Dr. Brandon Mancini is a radiation oncologist and Medical Director at BAMF Health, a leading theranostics center specializing in advanced personalized cancer treatments. He is passionate about expanding access to targeted cancer therapies and advancing the future of theranostics through innovation, patient care, and clinical research.
Resources Mentioned:
- BAMF Health Official Website - Learn more about theranostics and cancer treatment options
If you found this episode helpful, please share it with someone navigating cancer care or looking to learn more about emerging treatment options.
